|
Volumn 11, Issue 2, 2005, Pages
|
Evidence-based medicine: are SSRIs more effective than placebo and what length of therapy is enough?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
COMPARATIVE STUDY;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HUMAN;
MALE;
NOTE;
TIME;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HEADACHE;
HEALTH INSURANCE;
INSURANCE;
MEDICAL RECORD;
RANDOMIZED CONTROLLED TRIAL;
REPRODUCIBILITY;
STANDARD;
ANTIDEPRESSIVE AGENTS;
EVIDENCE-BASED MEDICINE;
HEALTH CARE COSTS;
HUMANS;
MALE;
PLACEBO EFFECT;
SEROTONIN UPTAKE INHIBITORS;
TIME FACTORS;
HEADACHE;
INSURANCE CLAIM REPORTING;
MANAGED CARE PROGRAMS;
MEDICAL RECORDS;
RANDOMIZED CONTROLLED TRIALS;
REPRODUCIBILITY OF RESULTS;
MLCS;
MLOWN;
|
EID: 33645832826
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2005.11.2.172 Document Type: Note |
Times cited : (4)
|
References (0)
|